GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms
Recruiting
Observational Study
Irritable Bowel Syndrome (IBS)
Genome-wide Association Study
Single Nucleotide Polymorphisms
Mediterranean Diet
FODMAP Diet
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Attikon Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Fulfillment of the Rome IV criteria for IBS
* Provision of written informed consent.
* Commitment of availability throughout the study period.
* IBS-SSS \> 175
Exclusion Criteria:
* Any concomitant disease requiring specialized nutrition (e.g. renal failure, diabetes, celiac…
Contacts